GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Mirion Technologies Inc (NYSE:MIR) » Definitions » Debt-to-EBITDA

MIR (Mirion Technologies) Debt-to-EBITDA : 2.83 (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Mirion Technologies Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Mirion Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $7.6 Mil. Mirion Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $712.3 Mil. Mirion Technologies's annualized EBITDA for the quarter that ended in Dec. 2024 was $254.0 Mil. Mirion Technologies's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 was 2.83.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Mirion Technologies's Debt-to-EBITDA or its related term are showing as below:

MIR' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -9.48   Med: 4.13   Max: 6.04
Current: 4.13

During the past 7 years, the highest Debt-to-EBITDA Ratio of Mirion Technologies was 6.04. The lowest was -9.48. And the median was 4.13.

MIR's Debt-to-EBITDA is ranked worse than
75.73% of 2291 companies
in the Industrial Products industry
Industry Median: 1.71 vs MIR: 4.13

Mirion Technologies Debt-to-EBITDA Historical Data

The historical data trend for Mirion Technologies's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mirion Technologies Debt-to-EBITDA Chart

Mirion Technologies Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-EBITDA
Get a 7-Day Free Trial - N/A -9.48 6.04 4.13

Mirion Technologies Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.77 6.19 4.26 4.54 2.83

Competitive Comparison of Mirion Technologies's Debt-to-EBITDA

For the Specialty Industrial Machinery subindustry, Mirion Technologies's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mirion Technologies's Debt-to-EBITDA Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Mirion Technologies's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Mirion Technologies's Debt-to-EBITDA falls into.


;
;

Mirion Technologies Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Mirion Technologies's Debt-to-EBITDA for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(7.6 + 712.3) / 174.4
=4.13

Mirion Technologies's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(7.6 + 712.3) / 254
=2.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2024) EBITDA data.


Mirion Technologies  (NYSE:MIR) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Mirion Technologies Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Mirion Technologies's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Mirion Technologies Business Description

Traded in Other Exchanges
Address
1218 Menlo Drive, Atlanta, GA, USA, 30318
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.
Executives
Loic Eloy officer: Industrial Group President 1218 MENLO DRIVE, ATLANTA GA 30318
Thomas D Logan director, officer: Chief Executive Officer C/O MIRION TECHNOLOGIES, INC., 1218 MENLO DRIVE, ATLANTA GA 30318
Christopher A. Moore officer: Chief Accounting Officer (PAO) C/O MIRION TECHNOLOGIES, INC., 1218 MENLO DRIVE, ATLANTA GA 30318
Brian Schopfer officer: Chief Financial Officer MIRION TECHNOLOGIES, INC., 1218 MENLO DRIVE, ATLANTA GA 30318
Gsam Holdings Llc director, 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Michael J Rossi officer: Medical Group President 230 PARK AVENUE, SUITE 3350, NEW YORK NY 10169
Sheila Rege director 1218 MENLO DRIVE, ATLANTA GA 30318
Jody Markopoulos director 3641 WOODBOURNE LANE, CROZET VA 22932
Ccp Ix Lp No. 1 10 percent owner 76 BUCKINGHAM PALACE ROAD, 6TH FLOOR, BELGRAVE HOUSE, LONDON X0 SW1W 9TQ
Ccp Ix Lp No. 2 10 percent owner 76 BUCKINGHAM PALACE ROAD, 6TH FLOOR, BELGRAVE HOUSE, LONDON X0 SW1W 9TQ
Ccp Ix Co-investment Lp 10 percent owner 76 BUCKINGHAM PALACE ROAD, 6TH FLOOR, BELGRAVE HOUSE, LONDON X0 SW1W 9TQ
Ccp Ix Co-investment No. 2 Lp 10 percent owner 76 BUCKINGHAM PALACE ROAD, 6TH FLOOR, BELGRAVE HOUSE, LONDON X0 SW1W 9TQ
Charterhouse General Partners (ix) Ltd 10 percent owner 76 BUCKINGHAM PALACE ROAD, 6TH FLOOR, BELGRAVE HOUSE, LONDON X0 SW1W 9TQ
Kipling Matas officer: Chief Accounting Officer MIRION TECHNOLOGIES, INC., 1218 MENLO DRIVE, ATLANTA GA 30318
Christopher L Warren director MIRION TECHNOLOGIES, INC., 1218 MENLO DRIVE, ATLANTA GA 30318